{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:37:23Z","timestamp":1778225843841,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.exer.2009.06.011","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T09:00:12Z","timestamp":1246525212000},"page":"718-727","source":"Crossref","is-referenced-by-count":24,"title":["Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP"],"prefix":"10.1016","volume":"89","author":[{"given":"Steven","family":"Budd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Byfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Martiniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pete","family":"Geisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2009.06.011_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1179\/joc.2004.16.Supplement-1.59","article-title":"Vascular endothelial growth factor (VEGF) inhibition by small molecules","volume":"16","author":"Ahmed","year":"2004","journal-title":"J. Chemother."},{"key":"10.1016\/j.exer.2009.06.011_bib2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/323712a0","article-title":"Disoriented pathfinding by pioneer neurone growth cones deprived of filopodia by cytochalasin treatment","volume":"323","author":"Bentley","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.exer.2009.06.011_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jtbi.2007.09.015","article-title":"Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation","volume":"250","author":"Bentley","year":"2008","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.exer.2009.06.011_bib4","first-page":"391","article-title":"Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity","volume":"39","author":"Berkowitz","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.06.011_bib5","doi-asserted-by":"crossref","first-page":"39867","DOI":"10.1074\/jbc.M007040200","article-title":"Platelet-derived Growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain","volume":"275","author":"Borges","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2009.06.011_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.exer.2009.06.011_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0029(19970101)36:1<1::AID-JEMT1>3.0.CO;2-V","article-title":"Glial, vascular and neuronal cytogenesis in whole-mounted cat retina","volume":"36","author":"Chan-Ling","year":"1997","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.exer.2009.06.011_bib8","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell division: evidence that \u2018physiological hypoxia\u2019 is the stimulus for normal retinal vasculogenesis","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.06.011_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2009.06.011_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1542\/peds.111.2.339","article-title":"Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?","volume":"111","author":"Chow","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.exer.2009.06.011_bib11","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity","volume":"245","author":"Chung","year":"2007","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2009.06.011_bib12","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(95)92475-2","article-title":"Transcutaneous oxygen levels in retinopathy of prematurity","volume":"346","author":"Cunningham","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2009.06.011_bib13","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2009.06.011_bib14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1600-0854.2006.00462.x","article-title":"Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells","volume":"7","author":"Ewan","year":"2006","journal-title":"Traffic"},{"key":"10.1016\/j.exer.2009.06.011_bib15","doi-asserted-by":"crossref","first-page":"C1358","DOI":"10.1152\/ajpcell.2001.280.6.C1358","article-title":"Role of vascular endothelial growth factor in regulation of physiological angiogenesis","volume":"280","author":"Ferrara","year":"2001","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.exer.2009.06.011_bib16","first-page":"99","article-title":"SU5416 Is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1\/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types","volume":"59","author":"Fong","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2009.06.011_bib17","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","article-title":"Involvement of integrins alpha vbeta 3 and alpha vbeta 5 in ocular neovascular diseases","volume":"93","author":"Friedlander","year":"1996","journal-title":"Proc. Natl. Acas. Sci. U S A"},{"key":"10.1016\/j.exer.2009.06.011_bib18","first-page":"345","article-title":"Neutralizing antibody to VEGF reduces intravitreous neovascularization and does not interfere with vascularization of avascular retina in an ROP model","volume":"14","author":"Geisen","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2009.06.011_bib19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1083\/jcb.200302047","article-title":"VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia","volume":"161","author":"Gerhardt","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exer.2009.06.011_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.yexcr.2007.10.026","article-title":"Lamellipodia nucleation by filopodia depends on integrin occupancy and downstream Rac1 signaling","volume":"314","author":"Guillou","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.exer.2009.06.011_bib21","article-title":"Filopodia: the fingers that do the walking","volume":"400","author":"Gupton","year":"2007","journal-title":"Sci STKE"},{"key":"10.1016\/j.exer.2009.06.011_bib22","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1167\/iovs.06-0450","article-title":"Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy","volume":"47","author":"Hartnett","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.06.011_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/02713689608995831","article-title":"The effect of postnatal growth retardation on abnormal neovascularization in the oxygen exposed neonatal rat","volume":"15","author":"Holmes","year":"1996","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2009.06.011_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-008-0786-7","article-title":"Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity","author":"Honda","year":"2008","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2009.06.011_bib25","series-title":"Strict Oxygen Management is Associated with Decreased Incidence of Severe of Retinopathy of Prematurity","author":"Hong","year":"2002"},{"key":"10.1016\/j.exer.2009.06.011_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10384-007-0506-6","article-title":"Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase","volume":"52","author":"Kami","year":"2008","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.exer.2009.06.011_bib27","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1038\/sj.onc.1210159","article-title":"Semaxinib (SU5416) as a therapeutic agent targeting oncogenic Kit mutants resistant to imatinib mesylate","volume":"26","author":"Kosmider","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exer.2009.06.011_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nbd.2006.12.020","article-title":"Neonatal hypoxic preconditioning involves vascular endothelial growth factor","volume":"26","author":"Laudenbach","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exer.2009.06.011_bib29","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1096\/fj.07-9509com","article-title":"Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo","volume":"22","author":"Levchenko","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.exer.2009.06.011_bib30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCRESAHA.107.155655","article-title":"Mechanisms of integrin vascular endothelial growth factor receptor cross-activation in angiogenesis","volume":"101","author":"Mahabeleshwar","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2009.06.011_bib31","first-page":"474","article-title":"Localization of VEGF receptor-2 (KDR\/Flk-1) and effects of blocking it in oxygen-induced retinopathy","volume":"43","author":"McLeod","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.06.011_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular Endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2009.06.011_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2009.06.011_bib34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1203\/00006450-199412000-00007","article-title":"Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat","volume":"36","author":"Penn","year":"1994","journal-title":"Pediatr. Res."},{"issue":"7","key":"10.1016\/j.exer.2009.06.011_bib35","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1083\/jcb.200704010","article-title":"Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors","volume":"179","author":"Pi","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exer.2009.06.011_bib36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.exer.2006.03.019","article-title":"Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials","volume":"83","author":"Rahimi","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2009.06.011_bib37","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1096\/fj.00-0598fje","article-title":"Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development","volume":"15","author":"Robinson","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.exer.2009.06.011_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvn045","article-title":"Besides adhesion: new perspectives of integrin functions in angiogenesis","author":"Serini","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.exer.2009.06.011_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI17808","article-title":"Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity","volume":"112","author":"Shih","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exer.2009.06.011_bib40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/01.RES.71.2.443","article-title":"Indirect relation between rises in oxygen consumption and left ventricular output at birth in lambs","volume":"71","author":"Smolich","year":"1992","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2009.06.011_bib41","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2009.06.011_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2337\/diab.44.1.98","article-title":"Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells","volume":"44","author":"Thieme","year":"1995","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.exer.2009.06.011_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","article-title":"Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity","volume":"38","author":"Travassos","year":"2007","journal-title":"Ophthalmic. Surg. Lasers Imaging"},{"key":"10.1016\/j.exer.2009.06.011_bib44","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1167\/iovs.05-1343","article-title":"Specific involvement of Src family kinase activation in the pathogenesis of retinal neovascularization","volume":"47","author":"Werdich","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.06.011_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tiv.2005.06.047","article-title":"Distribution, metabolism, and\u00a0excretion of the anti-angiogenic compound SU5416","volume":"20","author":"Ye","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.exer.2009.06.011_bib46","first-page":"887","article-title":"Neovascularization grading methods in a rat model of retinopathy of prematurity","volume":"41","author":"Zhang","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483509001717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483509001717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T05:19:56Z","timestamp":1589951996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483509001717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0014483509001717"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2009.06.011","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}